AbbVie exits major pharmaceutical industry lobbying groups
Dec. 15, 2022... The maker of one of the world’s most profitable medicines is exiting the pharma industry’s two major lobbying organizations next year.
Dec. 15, 2022... The maker of one of the world’s most profitable medicines is exiting the pharma industry’s two major lobbying organizations next year.
Oct. 21, 2022... Michelle McMurry-Heath’s abrupt exit from BIO shocked the biotech industry. Here’s the inside story of how her departure unfolded.
Oct. 13, 2022... What's going on at biotech's lobbying organization? Where does mRNA go from here? And what happens when startups close down? Find out on the latest episode of "The Readout LOUD" podcast. Listen now:
Oct. 11, 2022... Michelle McMurry-Heath resigned as head of the Biotechnology Innovation Organization following disagreements with some board members.
Oct. 9, 2022... Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington, is on leave from her role as CEO of the Biotechnology Innovation Organization, the group confirmed on Sunday.
Aug. 23, 2022... Biological systems are too complicated for the human brain to efficiently control. Computational machines can help humans tap into nature to solve some of the most pressing issues of the day.
Aug. 7, 2022... After a major vote Sunday, President Biden is on the verge of his own crowning health care achievement to call, in his words, a BFD.
July 26, 2022... Pharma’s lobbyists are staring down their biggest test yet, as Democrats barrel toward a vote on drug pricing reform.
May 17, 2022... U.S. policymakers and lawmakers need to broaden their vision beyond pandemic preparedness to include preparing for human-generated chemical, biological, radiological, and nuclear threats.
Feb. 16, 2022... As CEO for the world’s largest biotech lobbying organization, McMurry-Heath is a regular (virtual) presence on Capitol Hill, where she has spent the past year arguing against Biden administration proposals to impose price controls on drugs and suspend patent protection for vaccines. But McMurry-Heath, a molecular immunologist and former Johnson & Johnson executive, is also…
Sept. 21, 2021... Former FDA Commissioner Scott Gottlieb writes that he briefed Trump multiple times in the early days of the Covid-19 pandemic, roughly a year after he stepped down as FDA commissioner.
Aug. 31, 2021... One of the companies affected by recent FDA restrictions on certain vape makers is openly bragging that it found a loophole to stay in business.
Aug. 31, 2021... BIO, the lobbying group for biotech companies, is wrestling with inner turmoil that could threaten its ability to navigate Washington.
Aug. 18, 2021... Embedding delicate mRNA vaccine molecules inside lipid nanoparticle shells at temperatures colder than Antarctica isn't as easy as following a recipe from Bon Appetit.
Aug. 9, 2021... "Janet Woodcock is industry's favorite candidate. This is probably not a coincidence,” said Adriane Fugh-Berman of Georgetown University.
July 6, 2021... The STAT summer book list is back: Check out recommendations for great reads (and podcasts) from the likes of Anthony Fauci, @CDCDirector, @ChelseaClinton, STAT readers and staff, and more!
June 22, 2021... Sen. Bob Menendez (D-N.J.) escalated his campaign for a 9/11 Commission-style panel to investigate the government response to Covid-19 with a rally at a New Jersey hospital Monday.
June 21, 2021... Everyone wants to know whether BIO president Michelle McMurry-Heath will be Biden’s pick to lead the FDA — and whether she even wants the job. So we asked her.
May 21, 2021... With help from biotechnology, the U.S. can achieve the climate change goals outlined by the Biden administration. Human progress and technology got us into this mess. That same ingenuity can help get us out.
May 19, 2021... Turning an intellectual property waiver for Covid-19 vaccines into vaccine doses will require mobilization, investment, and advocacy for tech transfers, upgraded manufacturing capability, and strengthened supply chains.
May 6, 2021... The U.S.’s stunning endorsement of a proposal to waive Covid-19 vaccine patents has won plaudits for President Biden and roiled the global pharmaceutical industry. But, at least in the short term, it’s likely to be more of a symbolic milestone.
March 9, 2021... Both Trump and Obama had named FDA commissioner nominees by this week in their presidencies — and neither was dealing with a global pandemic.
March 3, 2021... For years, the antibiotics used to fight various infections have grown gradually less effective. If current trends continue, these antibiotics could stop working altogether in the near future.
Jan. 21, 2021... Eli Lilly says its monoclonal antibody prevented Covid-19 infections in nursing home residents and staff in a clinical trial, the first time such a treatment has been shown to prevent infection.
Jan. 12, 2021... Several major health corporations are re-evaluating their support for the 147 GOP lawmakers who voted against certifying the Electoral College results.
Dec. 4, 2020... EXCLUSIVE: The biotech trade group BIO is suing the Trump administration over its new drug pricing policy today.
Sept. 3, 2020... Among their demands: That biotech companies don’t simply release clinical trial data in press releases, and that regulators make it clear that any vaccines or treatments will be approved strictly based on science.
July 31, 2020... Pharma is skipping White House meetings and publicly questioning Trump’s resolve — a brazen new strategy for dealing with his efforts to lower drug prices.
July 16, 2020... Nov 16-19Online#statsummit About The 2020 STAT Summit: What’s next? The coronavirus pandemic has reset our expectations of what is possible. New medicines and vaccines are being developed at a previously unimaginable pace. Telemedicine has replaced the doctor’s office. Now, we’re starting to figure out how the world has been reshaped in the wake of Covid-19,…